Calling All Stage II Men Survivors!

Have you been diagnosed with stage II colon cancer? We need a few more men to complete a 30 minute survey to help inform a study focused on patients like you. If you were diagnosed with stage II colon cancer any time since 2010, researchers from the University of California-Los Angeles and the University of Pittsburgh…  Read More

Highlights from ASCO 2011

While there weren’t new blockbuster announcements for colorectal cancer this year at the American Society for Clinical Oncology’s (ASCO) Annual Meeting, there was plenty of focus on making what we already have work better and on choosing the patients who will benefit the most from treatments, as well as those who might not be helped at…  Read More

Chemo Delay After Surgery Reduces Survival Rates

A paper presented at the recent 2011 Gastrointestinal Cancers Symposium conference reported important evidence that, for colorectal cancer patients getting chemotherapy after surgery, the sooner the better. For people diagnosed with stage III colon cancer, stage II rectal cancer, or stage II colon cancer showing certain high-risk features, researchers found that each four-week delay in starting chemotherapy…  Read More

Leading GI Cancer Researcher Updates Patients

Last night, Dr. Edith Mitchell of Thomas Jefferson University Kimmel Cancer Center in Philadelphia, PA, updated colorectal cancer patients on the latest research and treatment news in an online webinar. Dr. Mitchell highlighted the most important news for colon and rectal cancer patients to come from the 2011 Gastrointestinal Cancers Symposium held in San Francisco last…  Read More

New GeneTest Guides Stage II Colon Cancer Risk

Most patients with stage II colon cancer will be fine after surgery, with little risk that their cancer will come back. But one in five will have cancer spread beyond their colon. Better information about which patients will relapse could spare many from the risks of chemotherapy. A new gene test announced at the 2011 Gastrointestinal…  Read More

DNA Mismatch Repair and 5-FU: What's the Connection?

Some colon cancer patients don’t benefit from treatment with 5-FU based chemotherapy and may even have worse outcomes than if they no chemo at all. Of every 100 people with colon cancer, about 15 will have cancers that arise when mistakes in DNA during cell division are not caught and fixed.  Scientists call this defective mismatch…  Read More